News
-
15.12.2021Captor Therapeutics to attend the 11th Annual LifeSci Partners Corporate Access Eventmore -
01.12.2021Captor Therapeutics Presents 3Q’21 Financial Results and Provides a Business Updatemore -
08.11.2021Captor Therapeutics is one of the founders of the BioInMed - Polish Association of Innovative Medical Biotechnology Companiesmore -
26.10.2021Captor Therapeutics to Present at the 4th Annual Targeted Protein Degradation SummitmoreDr. Michał Walczak will present on 28 October 2021
-
15.10.2021Captor Therapeutics presents H1 2021 financial results and provides business updatemoreCaptor presented data from its H1 2021 report during the WSE Innovation Day
-
11.10.2021GPW Innovation DaymoreCaptor Therapeutics will be present during upcoming Warsaw Stock Exchange Innovation Day
-
06.10.2021Zaproszenie na spotkanie z przedstawicielami Spółkimorecelem prezentacji i omówienia wyników finansowych za okres H1 2021. -
28.09.2021Captor Therapeutics reveals pipeline project targeting the undrugged target MCL-1moreThe Company today announced key preclinical data and revealed the identity of the drug target
-
14.09.2021Captor Therapeutics to Present at the 3rd European Protein Degradation Congress in SeptembermoreDr. Tom Shepherd will present on 21st September, 2021
-
30.08.2021Collaboration with LifeSci AdvisorsmoreCaptor Therapeutics S.A. has entered into an agreement with LifeSci Advisors LLC